201 related articles for article (PubMed ID: 9762888)
1. Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer.
Nakae S; Nakamura T; Ikegawa R; Yoshioka H; Shirono J; Tabuchi Y
J Surg Oncol; 1998 Sep; 69(1):28-35. PubMed ID: 9762888
[TBL] [Abstract][Full Text] [Related]
2. Nuclear DNA content and nucleolar organizer regions in colorectal cancer.
Adachi Y; Kido A; Mori M; Matsushima T; Shimono R; Inoue T; Sugimachi K
J Surg Oncol; 1995 Jul; 59(3):177-80. PubMed ID: 7609524
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of the cytophotometric DNA content and its relationship with the argyrophilic nucleolar organizer regions (AgNOR) and proliferating cell nuclear antigen (PCNA) in oesophageal cancer.
Kuwano H; Sumiyoshi K; Nozoe T; Yasuda M; Watanabe M; Sugimachi K
Eur J Surg Oncol; 1995 Aug; 21(4):368-73. PubMed ID: 7664900
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of proliferating cell nuclear antigen (PCNA) and argyrophilic nucleolar organizer region (AgNOR) in testicular tumors].
Ohyama C; Ito A; Tokuyama S; Nakazumi H; Suzuki K; Kawamura S; Sato M; Saito S; Yoshikawa K; Hoshi S
Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1543-51. PubMed ID: 7474604
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of nucleolar organizer regions in endoscopically biopsied tissues of colorectal cancers.
Yamaguchi A; Tsukioka Y; Kurosaka Y; Nishimura G; Kanno M; Yonemura Y; Miyazaki I
Oncology; 1993; 50(2):121-6. PubMed ID: 8451034
[TBL] [Abstract][Full Text] [Related]
6. [Significance of FCM-DNA ploidy pattern, AgNOR counting, hTERT and PCNA expression in differentiating malignant from benign serous effusion].
Wu LY; Liu BR; Lu J; Ling MD; Chen J; Li P; Jiang Y
Ai Zheng; 2007 Feb; 26(2):178-82. PubMed ID: 17298749
[TBL] [Abstract][Full Text] [Related]
7. Nucleolar organizer regions and PCNA expression in prostatic cancers.
Kawase N; Shiokawa A; Ota H; Saitoh T; Yoshida H; Kazama K
Pathol Int; 1994 Mar; 44(3):213-22. PubMed ID: 7517763
[TBL] [Abstract][Full Text] [Related]
8. PCNA immunostaining combined with AgNOR staining in esophageal squamous cell carcinoma to identify patients with a poor prognosis.
Morisaki Y; Shima S; Yoshizumi Y; Sugiura Y; Tanaka S; Tamai S
Surg Today; 1995; 25(5):389-95. PubMed ID: 7640465
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of DNA ploidy pattern and nucleolar organizer regions (AgNOR) in colorectal carcinoma.
Eminović-Behrem S; Trobonjaca Z; Petrovecki M; Dobi-Babić R; Dujmović M; Jonjić N
Croat Med J; 2000 Jun; 41(2):154-8. PubMed ID: 10853043
[TBL] [Abstract][Full Text] [Related]
10. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
11. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
Singh M; Prasad S; Kalra N; Singh U; Shukla Y
Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
[TBL] [Abstract][Full Text] [Related]
12. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
14. Analysis of proliferative activity using antiproliferating cell nuclear antigen antibody in colorectal cancer.
Nakae S; Nakamura T; Shirono J; Yoshioka H; Ikegawa R; Miyamura K; Kawasaki K; Saitoh Y; Tabuchi Y
J Surg Oncol; 1995 Nov; 60(3):149-53. PubMed ID: 7475063
[TBL] [Abstract][Full Text] [Related]
15. [Analyses of PCNA and AgNOR on advanced colorectal cancer as predictive indicators of the prognosis].
Nishi Y; Takano Y; Kakita A
Nihon Geka Gakkai Zasshi; 1994 Nov; 95(11):797-806. PubMed ID: 7830706
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen and nucleolar organizer region for differential diagnosis of dysplasia and adenocarcinoma in gastric biopsies.
Ozercan IH; Bahçecioglu IH; Ozercan MR; Bozlak N; Dogan C; Yekeler H
Indian J Gastroenterol; 2000; 19(2):57-60. PubMed ID: 10812815
[TBL] [Abstract][Full Text] [Related]
17. Proliferative activity in the malignant cellular blue nevus.
Pich A; Chiusa L; Margaria E; Aloi F
Hum Pathol; 1993 Dec; 24(12):1323-9. PubMed ID: 7903955
[TBL] [Abstract][Full Text] [Related]
18. Morphometric determination of AgNORs in breast carcinoma. Correlation with flow cytometry and proliferating cell nuclear antigen.
Bellotti M; Elsner B; Kahn A; Bezodnick L; Pisilli L; Greco P
Anal Quant Cytol Histol; 1997 Apr; 19(2):139-44. PubMed ID: 9113306
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
[TBL] [Abstract][Full Text] [Related]
20. The AgNOR technique, PCNA immunohistochemistry, and DNA ploidy in the evaluation of choroid plexus biopsy specimens.
Centeno BA; Louis DN; Kupsky WJ; Preffer FI; Sobel RA
Am J Clin Pathol; 1993 Dec; 100(6):690-6. PubMed ID: 7902669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
